168 related articles for article (PubMed ID: 19440555)
1. Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Hallberg M
Drug News Perspect; 2009 Apr; 22(3):133-9. PubMed ID: 19440555
[TBL] [Abstract][Full Text] [Related]
2. The angiotensin IV/AT4 receptor.
Chai SY; Fernando R; Peck G; Ye SY; Mendelsohn FA; Jenkins TA; Albiston AL
Cell Mol Life Sci; 2004 Nov; 61(21):2728-37. PubMed ID: 15549174
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
[TBL] [Abstract][Full Text] [Related]
4. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
[TBL] [Abstract][Full Text] [Related]
5. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
[TBL] [Abstract][Full Text] [Related]
6. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
9. Assessment of biological activity of novel peptide analogues of angiotensin IV.
Gard PR; Olivier G; Golding B; Bourner C; Dang T; Haliru H; Higgins E; Kimberley H; Loginova O; Madhavi S; Ryan D
J Pharm Pharmacol; 2011 Apr; 63(4):565-71. PubMed ID: 21401609
[TBL] [Abstract][Full Text] [Related]
10. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
Lee J; Albiston AL; Allen AM; Mendelsohn FA; Ping SE; Barrett GL; Murphy M; Morris MJ; McDowall SG; Chai SY
Neuroscience; 2004; 124(2):341-9. PubMed ID: 14980384
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Lew RA; Mustafa T; Ye S; McDowall SG; Chai SY; Albiston AL
J Neurochem; 2003 Jul; 86(2):344-50. PubMed ID: 12871575
[TBL] [Abstract][Full Text] [Related]
12. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
[TBL] [Abstract][Full Text] [Related]
13. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
14. Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory.
Albiston AL; Fernando RN; Yeatman HR; Burns P; Ng L; Daswani D; Diwakarla S; Pham V; Chai SY
Neurobiol Learn Mem; 2010 Jan; 93(1):19-30. PubMed ID: 19660563
[TBL] [Abstract][Full Text] [Related]
15. Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.
Demaegdt H; Gard P; De Backer JP; Lukaszuk A; Szemenyei E; Tóth G; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2011 Jun; 339(1-2):34-44. PubMed ID: 21457753
[TBL] [Abstract][Full Text] [Related]
16. Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain.
Ascher DB; Cromer BA; Morton CJ; Volitakis I; Cherny RA; Albiston AL; Chai SY; Parker MW
Biochemistry; 2011 Apr; 50(13):2611-22. PubMed ID: 21348480
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.
Wright JW; Harding JW
J Renin Angiotensin Aldosterone Syst; 2008 Dec; 9(4):226-37. PubMed ID: 19126664
[TBL] [Abstract][Full Text] [Related]
18. From angiotensin IV binding site to AT4 receptor.
Vanderheyden PM
Mol Cell Endocrinol; 2009 Apr; 302(2):159-66. PubMed ID: 19071192
[TBL] [Abstract][Full Text] [Related]
19. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
Weiland F; Verspohl EJ
Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
[TBL] [Abstract][Full Text] [Related]
20. Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.
Chai SY; Yeatman HR; Parker MW; Ascher DB; Thompson PE; Mulvey HT; Albiston AL
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S14. PubMed ID: 19090987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]